NEW YORK, NY: New Pre-Clinical Results Demonstrate That ALN-PCSsc Achieves Up to 90% PCSK9 Knockdown and Up to 68% Lowering of LDLc in Absence of Statins; Pre-clinical Durability Data Support Every-Two-Weeks Dosing ...
SOUTH SAN FRANCISCO, CA: Early Clinical Data on Combinations of TH-302 With Anti-Angiogenic Therapies in Solid Tumors; Preclinical Data on Combinations of TH-302 With Gemcitabine and Nab-Paclitaxel in Models of Pancreatic Can ...
Don't have an account yet? You can create one. As registered user you have some advantages like theme manager, comments configuration and post comments with your name.